Jessica Schaller
Acute Care · Clinton Township, MINPI 1144621459
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.2% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,164 and has fallen 72.3% since, to $322 in 2025. Among acute care clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $25.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$472
- Actelion Pharmaceuticals US, Inc.$457
- Kestra Medical Technology Services, Inc.$409
- Amgen$357
- Merck$341
- Abiomed$267
- plus $2K from 17 others
What the payments were for
- Food & beverage$3,65893%
- Education$2657%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 23 | $472 |
| Actelion Pharmaceuticals US, Inc. | 13 | $457 |
| Kestra Medical Technology Services, Inc. | 12 | $409 |
| Amgen | 18 | $357 |
| Merck | 18 | $341 |
| Abiomed | 2 | $267 |
| E.r. Squibb & Sons, L.L.C. | 14 | $255 |
| Pfizer | 8 | $230 |
| AstraZeneca | 6 | $178 |
| Scpharmaceuticals Inc. | 3 | $176 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $170 |
| Johnson & Johnson | 8 | $132 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $95 |
| Boehringer Ingelheim | 4 | $93 |
| Novo Nordisk | 2 | $56 |
| Boston Scientific | 2 | $44 |
| Lexicon Pharmaceuticals, Inc. | 3 | $42 |
| Abbott | 2 | $42 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| Edwards Lifesciences | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Atricure, Inc. | 1 | $19 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,923 in reported general payments places this provider in the 90th percentile of 567 acute care providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 176 | $190,191 |
| EntrestoSacubitril/Valsartan | 63 | $56,290 |
| JardianceEmpagliflozin | 31 | $28,466 |
| FarxigaDapagliflozin Propanediol | 24 | $21,355 |
| Repatha SureclickEvolocumab | 14 | $8,520 |
| Metoprolol Succinate | 209 | $3,313 |
| Ranolazine ErRanolazine | 19 | $1,905 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 19 | $903 |
| Nifedipine ErNifedipine | 36 | $797 |
| ClopidogrelClopidogrel Bisulfate | 22 | $634 |
| Rosuvastatin Calcium | 44 | $562 |
| Atorvastatin Calcium | 30 | $538 |
| SotalolSotalol Hcl | 25 | $500 |
| Carvedilol | 44 | $472 |
| Flecainide Acetate | 11 | $424 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $230 | $190,191176 claims |
| NovartisEntresto | $472 | $56,29063 claims |
| Boehringer IngelheimJardiance | $93 | $28,46631 claims |
| AstraZenecaFarxiga | $178 | $21,35524 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 567 acute care providers in Michigan.
Other acute care in Clinton Township
- Jeri ChardClinton Township$5K
- Janet WymanDetroit$103K
- Stephanie Mellon ReppenDetroit$57K
- Ashley WozniakLivonia$26K
- Julia BriggsBirch Run$16K
- Candise LovePort Huron$14K
- Janette GuertinPort Huron$14K
- Gregory AliNovi$13K
- Andrew PalmerLansing$9K
- Angela BrennanDearborn Heights$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.